Stay updated on Nivolumab in Untreated Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Untreated Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab in Untreated Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-lapse notice and Revision: v3.4.1.SummaryDifference0.3%

- Check20 days agoChange DetectedThe page displays a government funding notice about potential delays and the NIH Clinical Center's status. The revision history shows an update from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedUI text updates include Show glossary and Hide glossary options, along with minor capitalization tweaks in labels (e.g., Met QC Criteria vs met QC Criteria and Data vs data). The revision note shows the version bump from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedNew revision label added: Revision: v3.3.4 replaces v3.3.3, representing a minor UI update that does not affect the study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section now lists Texas (Houston, MD Anderson Cancer Center). Page revision updated to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Untreated Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Untreated Lung Cancer Clinical Trial page.